Merck (MRK) Shares Outstanding (Weighted Average) (2009 - 2026)

Merck (MRK) has 18 years of Shares Outstanding (Weighted Average) data on file, last reported at $2.5 billion in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $2.5 billion, down 2.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.5 billion (down 2.02% YoY), and the FY2025 annual result was $2.5 billion, down 1.18% from the prior year.
• Shares Outstanding (Weighted Average) slipped to $2.5 billion in Q1 2026 per MRK's latest filing, from $2.5 billion in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $2.5 billion in Q2 2023 and troughed at $2.5 billion in Q1 2026.
• A 5-year average of $2.5 billion and a median of $2.5 billion in 2022 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Weighted Average) grew 0.4% in 2023, then slipped 2.02% in 2026.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $2.5 billion in 2022, then rose by 0.2% to $2.5 billion in 2023, then retreated by 0.2% to $2.5 billion in 2024, then retreated by 1.18% to $2.5 billion in 2025, then slipped by 1.2% to $2.5 billion in 2026.
• Business Quant data shows MRK's Shares Outstanding (Weighted Average) at $2.5 billion in Q1 2026, $2.5 billion in Q4 2025, and $2.5 billion in Q3 2025.